Healthcare -
Biotechnology - NASDAQ - US
$ 3.5
-0.293 %
$ 670 M
Market Cap
-8.29
P/E
ABUS - NET INCOME
Net Income ABUS - Arbutus Biopharma Corporation
-69.9 M
LAST VALUE
-0.33%
2 YEAR CAGR
14.58%
5 YEAR CAGR
-6.06%
10 YEAR CAGR